Navrogen
Philadelphia
About Navrogen
Navrogen Inc. is a biopharmaceutical company that focuses on the targeted treatment of cancer. The company works on enhancing the immune system to fight cancer by removing the effect of factors produced or induced by tumor cells which inhibit the cancer-fighting humoral immune system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.2M
- Funding stage: Seed
- Last round: Grant (Sep 2025)
- Website: navrogen.com
- Phone: (610) 660-1931
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/navrogen-86038 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.